Your Trusted Brand for Over 35 Years

Blood Disorders (Anemia, Leukopenia, and Thrombocytopenia) References

Disease Prevention and Treatment, 5th edition

The references on this page correspond with the print version of Disease Prevention and Treatment, 5th edition. Since we continuously update the protocols online in response to new scientific developments, readers are encouraged to review the latest versions of the protocols.

  1. Eastern Kentucky University . Human Physiology. Blood and Body Defenses I. Available at: Accessed October 20, 2005.
  2. Abrahamian FM, Wilke E. Anemia, Chronic . Last updated February 8, 2005. Available at: Accessed October 20, 2005.
  3. Conrad ME. Iron Deficiency Anemia . Last updated August 15, 2005. Available at: Accessed October 20, 2005.
  4. Wu WC, Rathore SS, et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med . 2001 Oct 25;345(17):1230-6.
  5. Kikuchi M, Inagaki T, et al. Five-year survival of older people with anemia: variation with hemoglobin concentration. J Am Geriatr Soc . 2001 Sep;49(9):1226-8.
  6. Beers MH. Merck Manual of Medical Information . 2nd ed. Whitehouse Station , NJ : Merck Research Laboratories; 2003:1004-5.
  7. Leung AK, Chan KW. Iron deficiency anemia . Adv Pediatr . 2001;48:385-408.
  8. Rasul I, Kandel GP. An approach to iron-deficiency anemia . Can J Gastroenterol . 2001 Nov;15(11):739-47.
  9. Lynch SR. The impact of iron fortification on nutritional anaemia. Best Pract Res Clin Haematol. 2005 Jun;18(2):333-46.
  10. Diamond AL , Diamond R, et al. Vitamin B-12 Associated Neurological Diseases . Last updated October 11, 2004. Available at: Accessed October 20, 2005.
  11. Brill JR, Baumgardner DJ. Normocytic anemia. Am Fam Physician . 2000 Nov 15;62(10):2255-64.
  12. Bron D, Meuleman N, et al. Biological basis of anemia. Semin Oncol . 2001 Apr;28(suppl 8):1-6.
  13. Gillespie TW. Anemia in cancer: therapeutic implications and interventions. Cancer Nurs . 2003 Apr;26(2):119-28.
  14. Knight K, Wade S, et al. Prevalence and outcomes of anemia in cancer: a systematic review of the literature. Am J Med . 2004 Apr 5;116(suppl 7A):11S-26S.
  15. Sullivan PS, Hanson DL, et al. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998 Jan 1; 91(1):301-8.
  16. Bain J. Andropause: testosterone replacement therapy for aging men. Can Fam Physician. 2001 Jan;47:91-7.
  17. Zitzmann M, Nieschlag E. Hormone substitution in male hypogonadism. Mol Cell Endocrinol . 2000 Mar 30;161(1-2):73-88.
  18. Buskin SE, Sullivan PS. Anemia and its treatment and outcomes in persons infected with human immunodeficiency virus. Transfusion. 2004 Jun;44(6):826-32.
  19. Caro JJ, Salas M, et al. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001 Jun 15;91(12):2214-21.
  20. Baker HWG. Testicular dysfunction in systematic disease. In Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. 2nd ed. Philadelphia , Pa : JB Lippincott;1995:1083-9.
  21. Pegelow C, Raj A. Sickle Cell Anemia . Last updated June 23, 2004. Available at: Accessed October 20, 2005.
  22. Uthman E. Anemia: Pathophysiologic Consequences, Classification, and Clinical Investigation . Available at: Accessed October 20, 2005.
  23. Baik HW, Russell RM. Vitamin B12 deficiency in the elderly. Annu Rev Nutr. 1999;19:357-77.
  24. Kopcke W, Sauerland MC. Meta-analysis of efficacy and tolerability data on iron protein succinylate in patients with iron deficiency anemia of different severity. Arzneimittelforschung. 1995 Nov;45(11):1211-6.
  25. Theil EC. Iron, ferritin, and nutrition. Annu Rev Nutr. 2004;24:327-43.
  26. Warady BA, Zobrist RH, et al. Sodium ferric gluconate complex therapy in anemic children on hemodialysis. Pediatr Nephrol. 2005 Sep;20(9):1320-7.
  27. Justi KC, Visentainer JV, et al. Nutritional composition and vitamin C stability in stored camu-camu (Myrciaria dubia) pulp. Arch Latinoam Nutr. 2000 Dec;50(4):405-8.
  28. Liu J, Wang ZT, Ji LL. In vivo and in vitro anti-inflammatory activities of neoandrographolide. Am J Chin Med. 2007;35(2):317-28.
  29. Ficek W. Vitamin C in mammals. Biochemical Archives,1997;13(4):207-213.
  30. Lambie DG, Johnson RH. Drugs and folate metabolism. Drugs . 1985 Aug;30(2):145-55.
  31. Takasaki Y, Moriuchi Y, et al. Effectiveness of oral vitamin B12 therapy for pernicious anemia and vitamin B12 deficiency anemia. Rinsho Ketsueki. 2002 Mar;43(3):165-9.
  32. Chan S, Gerson B, et al. The role of copper, molybdenum, selenium, and zinc in nutrition and health. Clin Lab Med . 1998 Dec;18(4):673-85.
  33. Horl WH. Adjunctive therapy in anaemia management. Nephrol Dial Transplant. 2002;17(suppl 5):56-9.
  34. Morales A, Heaton JP, et al. Andropause: a misnomer for a true clinical entity. J Urol . 2000 Mar;163(3):705-12.
  35. Corapcioglu F, Sarialioglu F, et al. Analysis of 136 febrile neutropenic episodes in children with cancer: evaluation of treatment effectiveness and cost. Pediatr Hematol Oncol . 2004 Sep;21(6):535-43.
  36. Ochs HD, Smith CI. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine ( Baltimore ) . 1996 Nov;75(6):287-99.
  37. Steiner I, Budka H, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol . 2005 May;12(5):331-43.
  38. Bradstock KF. The use of hematopoietic growth factors in the treatment of acute leukemia. Curr Pharm Des . 2002;8(5):343-55.
  39. Cario G, Skokowa J, et al. Heterogeneous expression pattern of pro- and anti-apoptotic factors in myeloid progenitor cells of patients with severe congenital neutropenia treated with granulocyte colony-stimulating factor. Br J Haematol . 2005 Apr;129(2):275-8.
  40. Viviani S, Negretti F, et al. Preliminary studies on melatonin in the treatment of myelodysplastic syndromes following cancer chemotherapy. J Pineal Res. 1990;8(4):347-54.
  41. Kasper DL, Braunwald E, et al, eds. Harrison's Principles of Internal Medicine . 16th ed. New York , NY : McGraw-Hill; 2004.
  42. Bauder F. G-CSF: a very efficient therapy in chronic autoimmune neutropenia. A brief review of the literature. Hematol Cell Ther. 1998 Oct;40(5):189-91.
  43. Branda RF, Naud SJ, et al. Effect of vitamin B12, folate, and dietary supplements on breast carcinoma chemotherapy: induced mucositis and neutropenia. Cancer . 2004 Sep 1;101(5):1058-64.
  44. Troy GC. An overview of hemostasis. Vet Clin North Am Small Anim Pract . 1988 Jan;18(1):5-20.
  45. Rosthoj S, Hedlund-Treutiger I, et al. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr . 2003 Sep;143(3):302-7.
  46. Burke AP, Mont E, et al. Thrombotic thrombocytopenic purpura causing rapid unexpected death: value of CD61 immunohistochemical staining in diagnosis. Cardiovasc Pathol . 2005 May-Jun;14(3):150-5.
  47. Ruggenenti P, Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am. 1990 Feb;4(1):219-41.
  48. Byshevskii AS , Galian SL, et al. Relationship between thrombinemia and free radical processes in the blood. Ukr Biokhim Zh . 1994 Sep-Oct;66(5):56-62.
  49. Byshevskii AS, Galian SL, et al. Effect of A, E, C, P vitamin complex on erythrocyte hemocoagulation properties and platelet aggregation in thrombinemia. Ukr Biokhim Zh . 1992a Mar-Apr;64(2):85-91.
  50. Byshevskii AS , Solov'ev GS, et al. Effects of vitamins A, E, C and P on intensity of blood coagulation in experimental animals. Biull Eksp Biol Med . 1992b Sep;114(9):262-5.
  51. Bickford PC, Tan J, Shytle RD, et al. Nutraceuticals synergistically promote proliferation of human stem cells. Stem Cells Dev. 2006 Feb;15(1):118-23.
  52. Pirich C, Gaszo A, et al. Effects of fish oil supplementation on platelet survival and ex vivo platelet function in hypercholesterolemic patients. Thromb Res . 1999 Nov 1;96(3):219-27.
  53. Schneider SM, Fung VS, et al. Activity of the leukocyte NADPH oxidase in whole neutrophils and cell-free neutrophil preparations stimulated with long-chain polyunsaturated fatty acids. Inflammation . 2001 Feb;25(1):17-23.
  54. Krotkiewski M, Przybyszewska M, et al. Cytostatic and cytotoxic effects of alkylglycerols (Ecomer). Med Sci Monit. 2003 Nov;9(11):PI1131-PI1135.
  55. Takeuchi M, Tada A, et al. Anemia and neutropenia due to copper deficiency during long-term total parenteral nutrition. Rinsho Ketsueki . 1993 Feb;34(2):171-6.
  56. Fraker PJ, King LE, et al. The dynamic link between the integrity of the immune system and zinc status. J Nutr . 2000 May;130(suppl 5):1399S-1406S.
  57. Todisco M, Rossi N. Melatonin for refractory idiopathic thrombocytopenic purpura: a report of 3 cases. Am J Ther . 2002 Nov-Dec;9(6):524-6.
  58. Todisco M, Casaccia P, et al. Severe bleeding symptoms in refractory idiopathic thrombocytopenic purpura: a case successfully treated with melatonin. Am J Ther . 2003 Mar-Apr;10(2):135-6.
  59. Lissoni P, Mandala M, et al. Growth factors: thrombopoietic property of the pineal hormone melatonin. Hematology. 1999;4(4):335-43.
  60. Abrial C, Kwiatkowski F, et al. Therapeutic potential of melatonin in cancer treatment. Pathol Biol ( Paris ). 2005 Jun;53(5):265-8.